NR0B1
protein-codingnuclear receptor subfamily 0 group B member 1, the group of Nuclear receptor subfamily 0 group B
Gene summary
This gene encodes a protein that contains a DNA-binding domain. The encoded protein acts as a dominant-negative regulator of transcription which is mediated by the retinoic acid receptor. This protein also functions as an anti-testis gene by acting antagonistically to Sry. Mutations in this gene result in both X-linked congenital adrenal hypoplasia and hypogonadotropic hypogonadism. [provided by RefSeq, Jul 2008]
- AHC
- DSS
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~5.2 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: XL
Disease ID:MONDO:0010264
Submitter: G2P
Inheritance Pattern: XL
Disease ID:MONDO:0010226
Submitter: Ambry Genetics
Inheritance Pattern: XL
Disease ID:MONDO:0010264
Submitter: Orphanet
Inheritance Pattern: XL
Disease ID:MONDO:0010264
Submitter: PanelApp Australia
Inheritance Pattern: XL
Disease ID:MONDO:0010264
Submitter: Labcorp Genetics (formerly Invitae)
Inheritance Pattern: XL
Disease ID:MONDO:0010264
Submitter: Ambry Genetics
Inheritance Pattern: XLR
Disease ID:MONDO:0010264
Submitter: Natera
Inheritance Pattern: XL
Disease ID:MONDO:0010264
Submitter: Myriad Women's Health
Clinical Genomic Database (CGD)
Manifestation: Endocrine; Genitourinary; Obstetric; Oncologic
Intervention: Endocrine; Genitourinary; Obstetric; Oncologic
Rationale: Affected individuals typically present in infancy with acute-onset adrenal insufficiency, which can be lethal, and preventive and treatment measures can be effective
Comments: Digenic inheritance (with GNRH1) has been reported; Dosage-sensitive sex reversal has been described due to duplications
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to NR0B1 variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_000475.5. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 2 | 139 | 12 | 153 | ||
| missense | 11 | 10 | 116 | 24 | 8 | 169 |
| nonsense | 40 | 6 | 1 | 47 | ||
| start loss | 1 | 1 | 2 | |||
| frameshift | 49 | 7 | 1 | 57 | ||
| splice donor/acceptor (+/-2bp) | 7 | 1 | 8 | |||
| Total | 108 | 25 | 120 | 163 | 20 | 436 |
Highest pathogenic variant AF is 9.1685666e-7
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_000466.2 | 2 | MANE Select | |
| Ensembl | ENSP00000368253.4 | 2 | MANE Select | |
| Ensembl | ENSP00000368246.1 | 2 | Standard | |
| Ensembl | ENSP00000368246.1 | 2 | Standard |
Model Organisms & Knockout Phenotypes
Observed phenotypic effects in mouse and zebrafish models
| Gene / Model | Organism | Observed Phenotype |
|---|---|---|
| nr0b1 | Danio rerio | Structure: somatic cell Quality: decreased occurrence abnormal |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- NHR
- Nuclear Receptors
- Gene expression (Transcription)
- Generic Transcription Pathway
- Nuclear Receptor transcription pathway
Biological Process
- negative regulation of transcription by RNA polymerase II
- transcription initiation from RNA polymerase II promoter
- steroid biosynthetic process
- spermatogenesis
- protein localization
Molecular Function
- DNA-binding transcription factor activity, RNA polymerase II-specific
- DNA binding
- steroid hormone receptor activity
- transcription corepressor activity
- RNA binding
Cellular Component
- nucleus
- nucleoplasm
- cytoplasm
- microtubule organizing center
- membrane
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000378970
- Coding exons
- 2
- Length
- 5393
- Individuals with no LoFs
- 123291
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 1
- Defined
- 123292
- p
- 0.00000406
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | 1.08 | 150 | 192 | 0.780 | 0.0000132 | 3013 |
| Missense (PolyPhen) | 30 | 58.75 | 0.51063 | 1073 | ||
| Synonymous | -0.841 | 99 | 88.9 | 1.11 | 0.00000644 | 986 |
| Loss of Function | 3.06 | 0 | 10.9 | 0.00 | 6.93e-7 | 165 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0 | 0.0 | absent |
| Latino/Admixed American | 0.000037 | 0.000029 | rare |
| Ashkenazi Jewish | 0 | 0.0 | absent |
| East Asian | 0 | 0.0 | absent |
| Finnish | 0 | 0.0 | absent |
| European (Non-Finnish) | 0 | 0.0 | absent |
| South Asian | 0 | 0.0 | absent |
| Other | 0 | 0.0 | absent |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: Orphan nuclear receptor. Component of a cascade required for the development of the hypothalamic-pituitary-adrenal-gonadal axis. Acts as a coregulatory protein that inhibits the transcriptional activity of other nuclear receptors through heterodimeric interactions. May also have a role in the development of the embryo and in the maintenance of embryonic stem cell pluripotency (By similarity). {ECO:0000250}.;
- Disease
- DISEASE: Adrenal hypoplasia, congenital (AHC) [MIM:300200]: A disorder of adrenal gland development characterized by absence of the permanent zone of the adrenal cortex, structural disorganization of the adrenal glands, adrenal insufficiency and profound hormonal deficiencies. AHC patients manifest primary adrenal failure usually in early infancy, and hypogonadotropic hypogonadism leading to absent or incomplete sexual maturation. AHC can be inherited in an X-linked or autosomal recessive pattern. {ECO:0000269|PubMed:10323730, ECO:0000269|PubMed:10341858, ECO:0000269|PubMed:10675358, ECO:0000269|PubMed:10848616, ECO:0000269|PubMed:11113848, ECO:0000269|PubMed:11443184, ECO:0000269|PubMed:11748852, ECO:0000269|PubMed:11788621, ECO:0000269|PubMed:12629128, ECO:0000269|PubMed:15800903, ECO:0000269|PubMed:7990958, ECO:0000269|PubMed:9003500, ECO:0000269|PubMed:9063431, ECO:0000269|PubMed:9360549, ECO:0000269|PubMed:9415399, ECO:0000269|PubMed:9529340}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: 46,XY sex reversal 2 (SRXY2) [MIM:300018]: A condition characterized by male-to-female sex reversal in the presence of a normal 46,XY karyotype. {ECO:0000269|PubMed:9486644}. Note=The disease is caused by mutations affecting the gene represented in this entry. XY individuals with a duplication of part of the short arm of the X chromosome and an intact SRY gene develop as females. The single X chromosome in these individuals does not undergo X- chromosome inactivation; therefore, these individuals presumably carry 2 active copies of genes, including the NR0B1 gene, in the duplicated region. Individuals with deletion of this region develop as males. Genes within the dosage-sensitive sex reversal region are, therefore, not essential for testis development, but, when present in a double dose, interfere with testis formation.;
Recessive Scores
- pRec
- 0.610
Intolerance Scores
- LoFtool
- 0.0263
- RVIS EVS
- -0.49
- RVIS percentile EVS
- 22.09
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- N
- Essential (gene trap)
- N
- Indispensability pred.
- E
- Indispensability score
- 0.787
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |